NO952912L - En ny osteoblastisk proliferativ faktor - Google Patents
En ny osteoblastisk proliferativ faktorInfo
- Publication number
- NO952912L NO952912L NO952912A NO952912A NO952912L NO 952912 L NO952912 L NO 952912L NO 952912 A NO952912 A NO 952912A NO 952912 A NO952912 A NO 952912A NO 952912 L NO952912 L NO 952912L
- Authority
- NO
- Norway
- Prior art keywords
- new
- proliferative factor
- osteoblastic
- bone
- diseaese
- Prior art date
Links
- 230000001582 osteoblastic effect Effects 0.000 title 1
- 230000002062 proliferating effect Effects 0.000 title 1
- 208000010392 Bone Fractures Diseases 0.000 abstract 2
- 101000634196 Homo sapiens Neurotrophin-3 Proteins 0.000 abstract 2
- 102000004230 Neurotrophin 3 Human genes 0.000 abstract 2
- 108090000742 Neurotrophin 3 Proteins 0.000 abstract 2
- 210000000988 bone and bone Anatomy 0.000 abstract 2
- 102000057714 human NTF3 Human genes 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 229940032018 neurotrophin 3 Drugs 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20125794A JP3738281B2 (ja) | 1994-07-22 | 1994-07-22 | 新規な骨芽細胞増殖因子 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952912D0 NO952912D0 (no) | 1995-07-21 |
| NO952912L true NO952912L (no) | 1996-01-23 |
Family
ID=16437950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952912A NO952912L (no) | 1994-07-22 | 1995-07-21 | En ny osteoblastisk proliferativ faktor |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6080720A (no) |
| EP (1) | EP0704219B1 (no) |
| JP (1) | JP3738281B2 (no) |
| KR (1) | KR100361717B1 (no) |
| AT (1) | ATE206930T1 (no) |
| AU (1) | AU693567B2 (no) |
| CA (1) | CA2154403A1 (no) |
| DE (1) | DE69523250T2 (no) |
| DK (1) | DK0704219T3 (no) |
| ES (1) | ES2161809T3 (no) |
| FI (1) | FI953514A (no) |
| HU (1) | HU217082B (no) |
| NO (1) | NO952912L (no) |
| PT (1) | PT704219E (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5878477B2 (ja) * | 2010-01-15 | 2016-03-08 | ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー | 骨の治癒を加速するためのバナジウム化合物の使用 |
| WO2012079024A2 (en) | 2010-12-10 | 2012-06-14 | University Of Medicine And Dentistry Of New Jersey | Implantable devices coated with insulin-mimetic agent composites and methods thereof |
| US20140322292A1 (en) | 2010-12-10 | 2014-10-30 | Rutgers, The State University Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| US9931348B2 (en) | 2011-07-06 | 2018-04-03 | Rutgers, The State University Of New Jersey | Vanadium compounds as therapeutic adjuncts for cartilage injury and repair |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
| WO1995030434A1 (en) * | 1994-05-06 | 1995-11-16 | Regeneron Pharmaceuticals, Inc. | Methods based on the role of neurotrophin 3 in female reproduction |
-
1994
- 1994-07-22 JP JP20125794A patent/JP3738281B2/ja not_active Expired - Fee Related
-
1995
- 1995-07-18 DK DK95111224T patent/DK0704219T3/da active
- 1995-07-18 DE DE69523250T patent/DE69523250T2/de not_active Expired - Fee Related
- 1995-07-18 AT AT95111224T patent/ATE206930T1/de not_active IP Right Cessation
- 1995-07-18 EP EP95111224A patent/EP0704219B1/en not_active Expired - Lifetime
- 1995-07-18 ES ES95111224T patent/ES2161809T3/es not_active Expired - Lifetime
- 1995-07-18 PT PT95111224T patent/PT704219E/pt unknown
- 1995-07-20 AU AU27105/95A patent/AU693567B2/en not_active Ceased
- 1995-07-20 FI FI953514A patent/FI953514A/fi not_active IP Right Cessation
- 1995-07-21 US US08/505,539 patent/US6080720A/en not_active Expired - Fee Related
- 1995-07-21 KR KR1019950021475A patent/KR100361717B1/ko not_active IP Right Cessation
- 1995-07-21 NO NO952912A patent/NO952912L/no not_active Application Discontinuation
- 1995-07-21 HU HU9502202A patent/HU217082B/hu not_active IP Right Cessation
- 1995-07-21 CA CA002154403A patent/CA2154403A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR100361717B1 (ko) | 2003-07-07 |
| JPH0834744A (ja) | 1996-02-06 |
| EP0704219A2 (en) | 1996-04-03 |
| AU693567B2 (en) | 1998-07-02 |
| DK0704219T3 (da) | 2002-02-04 |
| ES2161809T3 (es) | 2001-12-16 |
| ATE206930T1 (de) | 2001-11-15 |
| EP0704219A3 (en) | 1997-12-10 |
| US6080720A (en) | 2000-06-27 |
| CA2154403A1 (en) | 1996-01-23 |
| FI953514A (fi) | 1996-01-23 |
| DE69523250D1 (de) | 2001-11-22 |
| HU217082B (hu) | 1999-11-29 |
| HUT73185A (en) | 1996-06-28 |
| PT704219E (pt) | 2002-03-28 |
| HU9502202D0 (en) | 1995-09-28 |
| NO952912D0 (no) | 1995-07-21 |
| KR960003741A (ko) | 1996-02-23 |
| DE69523250T2 (de) | 2002-07-04 |
| JP3738281B2 (ja) | 2006-01-25 |
| FI953514A0 (fi) | 1995-07-20 |
| EP0704219B1 (en) | 2001-10-17 |
| AU2710595A (en) | 1996-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69825292D1 (de) | Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen | |
| RU94027680A (ru) | Паращитовидный гормон и ралоксифон для увеличения массы кости, фармацевтический состав и способ увеличения костной массы | |
| UA29505C2 (uk) | Фармацевтична композиція для лікування і/або профілактики розрідження кістки і спосіб лікування і/або профілактики розрідження кістки у ссавців | |
| HUT77380A (hu) | Kombinált gyógyszerkészítmény alkalmazása sclerosis multiplex (MS) és más demielizáló állapotok kezelésére | |
| DE4497905T1 (de) | Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms | |
| ZA956029B (en) | Combination treatment for inhibiting bone loss | |
| ES2173111T3 (es) | Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos. | |
| MX9710252A (es) | Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento. | |
| BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
| DE69420776D1 (de) | Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| DE69426530D1 (de) | Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz | |
| BR9710250A (pt) | Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina | |
| NO952912L (no) | En ny osteoblastisk proliferativ faktor | |
| EP0744176A3 (en) | Methods for inhibiting bone loss | |
| RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| NO20010984D0 (no) | Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser | |
| IT1276706B1 (it) | Bicarbonati di derivati della 2,6-dimetilanilina, loro uso in terapia e composizioni farmaceutiche che li comprendono | |
| AU639693B2 (en) | Laser apparatus for treating bone and tooth tissue | |
| IL103499A0 (en) | Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients | |
| NO974941L (no) | Ny anvendelse av (S)-adenosyl-L-metionin(SAMe) | |
| SG64899A1 (en) | Method and composition for treatment of patients having decompsated liver disease | |
| PL54844Y1 (en) | Dental surgeon's syringe | |
| DE59405654D1 (de) | T-lymphozyten enthaltende pharmazeutische zusammensetzung zur behandlung von infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |